Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion

Table 1

General characteristics of the patients.

	IVT + GLP	IVB + GLP	P value
Number of eyes	52	47	—
Age (years)	62.8±8.4	64.6±8.7	𝑃=0.48
Gender (male/female)	32/20	28/19	𝑃=0.42
Hypertension (%)	35 (67.3%)	26 (55.4%)	𝑃=0.18
Diabetes (%)	12 (22.8%)	11 (23.6%)	𝑃=0.27
Hyperlipidemia (%)	4 (7.6%)	4 (8.6%)	𝑃=0.41
Fluorescein angiography; (nonischemic/ischemic)	43/9	30/17	𝑃=0.29
Localization of BRVO (superotemporal/inferotemporal)	38/14	31/16	𝑃=0.48
Initial IOP (mmHg)	15.0±2.0	15.2±2.0	𝑃=0.89
Last IOP (mmHg)	16.0±1.8	15.1±2.4	𝑃=0.12

IVA: intravitreal triamcinolone; GLP: grid laser photocoagulation; IVB: intravitreal bevacizumab; P: P value; BRVO: branch retinal vein occlusion; IOP: intraocular pressure. ^∗𝑃 value less than 0.05 was considered statistically significant. 𝑃 values are for IVT versus IVB groups.